The aim of this work was to design an add-on instrument that could potentially decrease the recurrence of non-muscle invasive bladder cancer. The current surgical approach permits spilled tumour cells to disseminate within the bladder, re-implant and cause tumour recurrence. An add-on instrument has been designed in the form of an opening cone intended to provide space for surgery and yet reduce tumour cell spillage and dissemination. A prototype was manufactured using the shape memory metal Nitinol which was activated using an electrical current to facilitate opening and supplemented with latex to provide a sealed environment. The prototype was tested in comparable surgical conditions utilising porcine bladder wall and blue dye to simulate tumour cells. It was demonstrated that the vast majority of dye was retained within the device, supporting the proposed aim.
LorussoVSilvestrisN.Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions. Ann Oncol2005; 16: iv85–iv89.
5.
Van RhijnBWGBurgerMLotanY. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol2009; 56: 430–442.
6.
SylvesterRJvan der MeijdenAPMOosterlinckW. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol2006; 49: 466–477.
7.
BabjukMOosterlinckWSylvesterR. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol2011; 59: 997–1008.
8.
Advanced Bladder Cancer (ABC) Meta-Analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol2005; 48: 202–205.
9.
WallaceDBryanRDunnJ. Delay and survival in bladder cancer. BJU Int2002; 89: 868–878.
10.
BlandyJReynardJNotleyR.Transurethral resection. 5th ed.London: Taylor & Francis, 2005.
11.
WilbyDThomasKRayE. Bladder cancer: new TUR techniques. World J Urol2009; 27: 309–312.
12.
RayEO’BrienT.Should urologists be spending more time on the golf course?BJU Int2007; 100: 728–729.
13.
BryanRTCollinsSIDaykinMC. Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl2010; 92: 519–524.
14.
KondasJKissLHatarA. The effect of intravesical mitomycin C on the recurrence of superficial (Ta-T1) bladder cancer. A Hungarian Multicenter Study. Int Urol Nephrol1999; 31: 451–456.
15.
PatelPBryanRTWallaceDMA. Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance. Sci World J2011; 11: 2550–2558.
16.
SangarVKRagavanNMatanheliaSS. The economic consequences of prostate and bladder cancer in the UK. BJU Int2005; 95: 59–63.
17.
SvatekRSHollenbeckBKHolmängS. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol2014; 66: 253–262.
18.
BachTMuschterRHerrmannTRW. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspective. BJU Int2015; 115: 14–23.
19.
BS EN ISO 16061:2009. Instrumentation for use in association with non-active surgical implants – general requirements.
20.
BS ISO 8600-1:2013.Endoscopes – medical endoscopes and endotherapy devices: part 1: general requirements.
21.
PanditJJCareyA.Estimating the duration of common elective operations: implications for operating list management. Anaesthesia2006; 61: 768–776.
22.
VillanuevaAAJoshiKBBlottmanJB. A bio-inspired shape memory alloy composite (BISMAC) actuator. Smart Mater Struct2010; 19: 025013.
23.
DuerigTPeltonAStöckelD.An overview of nitinol medical applications. Mat Sci Eng A: Struct1999; 275: 149–160.
24.
MachadoLGSaviMA.Medical applications of shape memory alloys. Braz J Med Biol Res2003; 36: 683–691.
25.
OtsukaKWaymanC.Shape memory materials. Cambridge: Cambridge University Press, 1999.
26.
MorganNBroadleyM. Taking the art out of smart! Forming processes and durability issues for the application of NiTi shape memory alloys in medical devices. In: Medical device materials: proceedings of the materials and processes for medical devices conference, Anaheim, CA, 8–10 September 2003, pp. 247–252. Materials Park, OH: ASM International.
27.
BryanRTZeegersMPvan RoekelEH. A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years. BJU Int2013; 112: 169–175.
